Warfarin no better than aspirin in patients with heart failure

Warfarin did not reduce the rate of the combined endpoint of death, ischemic stroke, or intracerebral hemorrhage compared with aspirin, according to a Late Breaking Clinical Trial presented at the 2012 International Stroke Conference. Both warfarin and aspirin are used in this clinical setting, but until now, the two have never been compared in a head-to-head trial in heart failure patients.

Patients with heart failure in sinus rhythm are at an increased risk of stroke and death due to thrombotic events; however, the preferred antithrombotic regimen for treating this population is controversial.

The prevalence of heart failure in India due to coronary heart disease, hypertension, obesity, diabetes, and rheumatic heart disease has been estimated to range from 1.3 million to 4.6 million, with...

Related Articles

Clopidogrel plus aspirin can cause more harm than good in small subcortical stroke prevention

Using checklist helps to prevent heart failure readmissions

Galectin-3 identifies subset of heart failure patients who can benefit from a statin

Thrombolysis may be beneficial later and in older patients suffering an acute stroke